Insights

Growth through Acquisition Ambry Genetics was acquired by Tempus AI in early 2025 for $600 million, indicating a strong interest in expanding genetic testing and precision medicine capabilities, which presents opportunities to offer complementary innovative testing solutions and integration services.

Digital Platform Enhancement The recent launch of the Ambry CARE Program enhancement signals a focus on streamlining cancer risk assessment and genetic testing workflows, creating potential for partnerships around advanced digital health tools and workflow integration software.

Strategic Collaborations Partnerships with institutions like UC Irvine and PacBio demonstrate a strategic emphasis on rare disease research and genomics innovation, opening avenues to collaborate on research services, data analytics, and specialized testing solutions.

Market Expansion and Recognition Ambry Genetics’ recognition as a top workplace and its expanding database in collaboration with academic and industry partners highlight a strong reputation and customer trust, which can be leveraged for enterprise sales and strategic alliances.

Technology Stack Strength Utilizing advanced technologies such as Databricks, Amazon S3, and Docker Swarm positions Ambry Genetics as a tech-forward company, inviting opportunities for enterprise solutions that enhance data management, cloud infrastructure, and automation in genetic testing.

Ambry Genetics Tech Stack

Ambry Genetics uses 8 technology products and services including Databricks, Docker Swarm, Amazon S3, and more. Explore Ambry Genetics's tech stack below.

  • Databricks
    Big Data Processing
  • Docker Swarm
    Containerization
  • Amazon S3
    Content Delivery Network
  • Workato
    Data Integration
  • Microsoft 365
    Email
  • UltiPro
    Human Resource Management System
  • iClarity B2B2C
    Marketing Automation
  • X-Content-Type-Options
    Web & Portal Technology

Media & News

Ambry Genetics's Email Address Formats

Ambry Genetics uses at least 1 format(s):
Ambry Genetics Email FormatsExamplePercentage
FLast@ambrygen.comJDoe@ambrygen.com
93%
First.Last@ambrygen.comJohn.Doe@ambrygen.com
6%
FMiddleLast@ambrygen.comJMichaelDoe@ambrygen.com
1%

Frequently Asked Questions

What is Ambry Genetics's phone number?

Minus sign iconPlus sign icon
You can contact Ambry Genetics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ambry Genetics's official website and social media links?

Minus sign iconPlus sign icon
Ambry Genetics's official website is ambrygen.com and has social profiles on LinkedInCrunchbase.

What is Ambry Genetics's SIC code NAICS code?

Minus sign iconPlus sign icon
Ambry Genetics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ambry Genetics have currently?

Minus sign iconPlus sign icon
As of December 2025, Ambry Genetics has approximately 988 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer (ceo): T. S.Chief Medical Officer: S. L.Chief Financial Officer: M. M.. Explore Ambry Genetics's employee directory with LeadIQ.

What industry does Ambry Genetics belong to?

Minus sign iconPlus sign icon
Ambry Genetics operates in the Biotechnology Research industry.

What technology does Ambry Genetics use?

Minus sign iconPlus sign icon
Ambry Genetics's tech stack includes DatabricksDocker SwarmAmazon S3WorkatoMicrosoft 365UltiProiClarity B2B2CX-Content-Type-Options.

What is Ambry Genetics's email format?

Minus sign iconPlus sign icon
Ambry Genetics's email format typically follows the pattern of FLast@ambrygen.com. Find more Ambry Genetics email formats with LeadIQ.

When was Ambry Genetics founded?

Minus sign iconPlus sign icon
Ambry Genetics was founded in 1999.

Ambry Genetics

Biotechnology ResearchCalifornia, United States501-1000 Employees

Ambry Genetics, a Tempus company, translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Its unparalleled track record of discoveries over 25 years, and growing database that continues to expand in collaboration with academic, corporate, and pharmaceutical partners, means Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions.

Hiring Fraud Alert: Ambry has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry recruiter(s).

If you’ve experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://www.ambrygen.com/company/careers/recruitment-fraud-alert to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://ambrygen.com/careers.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1999
Employees
501-1000

Section iconFunding & Financials

  • $250M$500M

    Ambry Genetics's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Ambry Genetics's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.